⌘K

Login Start Free

Home/Filings/5/0001570523-18-000014

5//SEC Filing

DAILEY ROBERT JACKMAN 5

Accession 0001570523-18-000014

CIK 0001559356other

View on SEC.gov Company Profile

Filed

Mar 29, 8:00 PM ET

Accepted

Mar 30, 3:12 PM ET

Size

47.3 KB

Accession

0001570523-18-000014

Insider Transaction Report

Form 5

Period: 2017-12-31

Immune Therapeutics, Inc.IMUN

DAILEY ROBERT JACKMAN

Other

Transactions

Purchase
Common stock
2016-04-18$0.19/sh+500$95→ 20,800,359 total
Purchase
Common stock
2016-04-18$0.18/sh+3,420$633→ 20,800,359 total
Purchase
Common stock
2016-04-18$0.18/sh+100$18→ 20,800,359 total
Purchase
Common stock
2016-04-18$0.19/sh+500$94→ 20,800,359 total
Purchase
Common stock
2016-04-27$0.17/sh+2,000$348→ 20,800,359 total
Purchase
Common stock
2016-05-04$0.15/sh+1,000$148→ 20,800,359 total
Purchase
Common stock
2016-03-24$0.16/sh+1,000$156→ 20,800,359 total
Purchase
Common stock
2016-03-31$0.17/sh+1,000$170→ 20,800,359 total
Purchase
Common stock
2016-04-06$0.15/sh+5,100$768→ 20,800,359 total
Purchase
Common stock
2016-04-14$0.17/sh+500$84→ 20,800,359 total
Purchase
Common stock
2016-04-18$0.18/sh+5,000$925→ 20,800,359 total
Purchase
Common stock
2016-04-18$0.19/sh+500$95→ 20,800,359 total
Purchase
Common stock
2016-04-21$0.17/sh+200$34→ 20,800,359 total
Purchase
Common stock
2016-03-24$0.15/sh+1,250$193→ 20,800,359 total
Purchase
Common stock
2016-03-24$0.16/sh+1,000$157→ 20,800,359 total
Purchase
Common stock
2016-03-28$0.14/sh+5,000$719→ 20,800,359 total
Purchase
Common stock
2016-04-15$0.16/sh+3,500$566→ 20,800,359 total
Purchase
Common stock
2016-04-18$0.18/sh+1,680$309→ 20,800,359 total
Purchase
Common stock
2016-04-18$0.19/sh+300$56→ 20,800,359 total
Purchase
Common stock
2016-03-24$0.16/sh+750$117→ 20,800,359 total
Purchase
Common stock
2016-03-29$0.14/sh+5,000$687→ 20,800,359 total
Purchase
Common stock
2016-04-06$0.15/sh+5,000$760→ 20,800,359 total
Purchase
Common stock
2016-04-06$0.15/sh+900$134→ 20,800,359 total
Purchase
Common stock
2016-04-18$0.19/sh+1,000$192→ 20,800,359 total
Purchase
Common stock
2016-03-30$0.15/sh+5,000$775→ 20,800,359 total
Purchase
Common stock
2016-04-06$0.15/sh+1,250$187→ 20,800,359 total
Purchase
Common stock
2016-04-06$0.15/sh+3,750$570→ 20,800,359 total
Purchase
Common stock
2016-04-06$0.15/sh+200$30→ 20,800,359 total
Purchase
Common stock
2016-04-08$0.15/sh+3,000$449→ 20,800,359 total
Purchase
Common stock
2016-04-26$0.17/sh+200$34→ 20,800,359 total

Documents

1 file

5
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Immune Therapeutics, Inc.

CIK 0001559356

Entity typeother

Related Parties

1

filerCIK 0001570523

Filing Metadata

Form type: 5
Filed: Mar 29, 8:00 PM ET
Accepted: Mar 30, 3:12 PM ET
Size: 47.3 KB

View on SEC.gov